Michocki R J, Richardson J P
University of Maryland Medical System.
Md Med J. 1992 May;41(5):397-400.
Histamine-2 receptor antagonists have been available for fifteen years for the treatment of peptic ulcer disease and related disorders. While very safe, clinicians need to know correct dosing guidelines, drug interactions, and side effect profiles. Long-term therapy should be reserved for patients at high risk of recurrence.